[The prevention of hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy].
Wang
Gui-Qiang
GQ
D000970:Antineoplastic Agents; D000075202:Contraindications; D003603:Cytotoxins; D006509:Hepatitis B / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents; D014775:Virus Activation
D000970:Antineoplastic Agents; D003603:Cytotoxins; D007166:Immunosuppressive Agents